Live Webinar for Therapists. Complete both sessions for 10 Contact Hours (1.0 CEUs)
June 4 and 5, 2021
Course Times TDB
This comprehensive course delves into the impact on therapy from drugs that are designed to treat pain, musculoskeletal, respiratory, cardiovascular, nervous system, and endocrine disorders.
More information coming soon!
June 4 and 5, 2021
Course Times TDB
Patients undergoing therapy routinely take both prescription drugs and OTC medicines that ultimately influence treatment outcomes. Therapists with knowledge of these medicines practice safer, more effective therapy. The course will examine Rx and non-Rx medicine used in the therapy setting and will cover side effects that influence treatment and outcomes. Information will focus on drug actions and patient errors when treating pain, as well as common disorders of the musculoskeletal, neurologic, cardiorespiratory, and endocrine systems. Common OTC drugs and herbals are examined for occult hazards and drug interactions. Electronic resources for free drug-related information will be demonstrated.
Upon completion of this course, the participant will:
1. Describe basic factors that control drug uptake, bioavailability, and metabolism.
2. List benefits, limitations, and adverse effects of drug families used to treat inflammation and pain.
3. Classify drug families and drugs used to treat disorders and diseases of the musculoskeletal, neurological, cardiorespiratory, and endocrine systems.
4. Describe how drug choices and administration influence therapy outcomes, including common errors in drug administration committed by patients.
5. Define potential harms and drug interactions for over-the-counter medications and herbals.
Mark S. Nash, Ph.D., FACSM is a dynamic instructor who is highly regarded for his ability to take complex information and make it meaningful and clinically relevant. His pharmacology courses have earned widespread kudos for ease of understanding and relevance to therapy practice. He is a tenured Professor of Neurological Surgery and Rehabilitation Medicine at the Miller School of Medicine, University of Miami, Principal Investigator for The Miami Project to Cure Paralysis, and Director of Research in Rehabilitation Medicine. He holds graduate degrees in Human Biology, Applied Physiology, and Clinical Anatomy, and was a Doctoral Fellow focusing on rehabilitation of ischemic heart disease. Dr. Nash has taught doctoral coursework in Pharmacology in two distinguished Physical Therapy Programs, and has presented more than 100 continuing education programs nationwide. He has published more than 100 manuscripts, scholarly monographs, and book chapters on topics in rehabilitation physiology.
"The course was extremely informative but what made the course a home run was the presenter; Mark Nash. He presented the material in an extremely organized and efficient way with dabs of good humor, and the patience to adeptly answer all questions." - -Joshua Shulman
"Dr. Nash was very engaging! He made the material both interesting and applicable to various therapy settings. This course served to better explain common medications and their interactions." - -Nora Seader
Every physical, occupational and speech therapist treating patients in any clinical setting should take this course! It will change the way you look at medication reconciliation-and change the way you consider the plan of care in relation to patient's medications." --Joana Brooks
"This was one of the most informative and interesting courses I have every been to in years. Dr. Nash was fantastic. I would recommend this course to any discipline in need of a good pharmacology review." --
Webinar
LIVE WEBINAR
Directions
This course meets the criteria for 10 contact hours (1.0) CEUs, Intermediate Level. Most Physical Therapy State Boards accept webinars as a live offering. Please check with your state board to confirm. Application has been made to the NJ Board of Physical Therapy Examiners. Application has been made to the FL Physical Therapy Association for 12 continuing education contact hours.
Approved sponsor by the State of IL Department of Financial and Professional Regulation for Physical Therapy for 12 contact hours. Approved provider by the NY State Board of Physical Therapy for 12 contact hours (1.2 CEUs).
Education Resources, Inc. is an approved provider for Physical Therapy CEUs in the following states: KY, CA and TX.
The following state boards of physical therapy accept other states’ approval: AK, AR, AZ, DC, DE, GA, HI, ID, IN, KS, MI, MO, MS, NC, OR, PA, RI, SC, UT, VA, VT, WI, WY.
The following state boards of physical therapy either do not require course pre-approval or do not require CEUs for re-licensure: AL, CO, CT, IA, MA, ME, MT, NE, ND, NH, SD, WA.
Approved provider of continuing education by the American Occupational Therapy Association #3043, for 10 contact hours (1.0 CEUs) - Intermediate Level Occupational Therapy Process: assessment, intervention. The assignment of AOTA CEUs does not imply endorsement of specific course content, products or clinical procedures by AOTA.
This course is offered for up to 10 ASHA CEUs (Intermediate level, Professional area). This program has been submitted for approval of 10 clock hours of continuing education credit by the TX Speech Language-Hearing-Association (TSHA). TSHA approval does not imply endorsement of course content, specific products or clinical procedures.
NBCOT professional development provider – 10 PDUs.
Approved provider of the FL Board of Occupational Therapy-CE Broker 12- hours. This course meets the approval of the TX Board of OT Examiners.
10 hours of this course qualify towards the discipline-specific hours for the 20-hour requirement for NDTA re-certification. They do NOT qualify towards the 8-hour NDTA Instructor requirement for re-certification.